Curran Financial Partners, LLC Pfizer Inc Transaction History

Curran Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $175,642 - $229,281	4,207 New	4,207 $215,000
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $10,888 - $12,909	234 Added 6.04%	4,111 $216,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $5,993 - $7,426	-131 Reduced 3.27%	3,877 $201,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $165,610 - $245,490	4,008 New	4,008 $237,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Curran Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Curran Financial Partners, LLC with notifications on news.